• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

累积缺陷作为心血管发病率和死亡率的一个关键风险因素:154000 人的汇总分析。

Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals.

机构信息

Department of Medicine McMaster University Hamilton Canada.

Population Health Research Institute McMaster University and Hamilton Health Sciences Hamilton Canada.

出版信息

J Am Heart Assoc. 2020 Feb 4;9(3):e014686. doi: 10.1161/JAHA.119.014686. Epub 2020 Jan 28.

DOI:10.1161/JAHA.119.014686
PMID:31986990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7033862/
Abstract

Background Frailty is associated with higher mortality in individuals at high cardiovascular disease (CVD) risk. We hypothesize that frailty is a more important prognostic factor than CVD risk factors and aim to determine the prognostic value of a cumulative deficit frailty index in patients with or at high risk for CVD. Methods and Results We conducted an individual-level pooled analysis of participants with or at risk for CVD, recruited in 14 multicenter clinical trials. The cumulative deficit index was calculated as the proportion of 26 deficits exhibited. Individuals were categorized as nonfrail, prefrail, or frail if they had indexes of ≤0.1, >0.1 to 0.21, or >0.21, respectively. CVD risk was assessed using the Framingham score. Outcomes included CVD event (new or recurrent myocardial infarction, stroke, or heart failure) and mortality. We studied 154 696 patients (mean age, 70.8 years; 63% men) with median follow-up of 3.2 years. There were 17 535 CVD events and 15 067 deaths. The frail group (n=13 872) had higher risk of a CVD event (incidence rate ratio, 1.97; 95% CI, 1.85-2.08), all-cause mortality (hazard ratio, 1.91; 95% CI, 1.79-2.03), and CVD mortality (hazard ratio, 1.91; 95% CI, 1.77-2.05) than the nonfrail group (n=101 343). Associations remained unchanged after adjusting for CVD risk factors. The index statistically outperformed the Framingham score in its ability to discriminate CVD events (C-statistic, 0.60 [95% CI, 0.60-0.61] versus 0.58 [95% CI, 0.57-0.58], respectively; <0.001). Conclusions In individuals with or at high risk of developing CVD, the cumulative deficit index is associated with increased CVD events and mortality, independent of CVD risk factors, and adds incremental prognostic value.

摘要

背景

衰弱与心血管疾病(CVD)高危人群的死亡率升高有关。我们假设衰弱是比 CVD 危险因素更重要的预后因素,并旨在确定累积缺陷衰弱指数在患有 CVD 或有 CVD 风险的患者中的预后价值。

方法和结果

我们对患有 CVD 或有 CVD 风险的参与者进行了一项个体水平的汇总分析,这些参与者是在 14 项多中心临床试验中招募的。累积缺陷指数的计算方法是表现出的 26 个缺陷的比例。如果指数≤0.1、>0.1 至 0.21 或>0.21,则将个体归类为非虚弱、虚弱前期或虚弱。使用 Framingham 评分评估 CVD 风险。结局包括 CVD 事件(新发或复发性心肌梗死、卒中和心力衰竭)和死亡率。我们研究了 154696 名患者(平均年龄 70.8 岁,63%为男性),中位随访时间为 3.2 年。发生 17535 例 CVD 事件和 15067 例死亡。虚弱组(n=13872)发生 CVD 事件的风险更高(发生率比,1.97;95%CI,1.85-2.08)、全因死亡率(风险比,1.91;95%CI,1.79-2.03)和 CVD 死亡率(风险比,1.91;95%CI,1.77-2.05)高于非虚弱组(n=101343)。调整 CVD 危险因素后,相关性仍然不变。该指数在区分 CVD 事件方面的能力优于 Framingham 评分(C 统计量,0.60[95%CI,0.60-0.61]与 0.58[95%CI,0.57-0.58];<0.001)。

结论

在患有 CVD 或有 CVD 风险的人群中,累积缺陷指数与 CVD 事件和死亡率的增加相关,独立于 CVD 危险因素,并增加了额外的预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/a4dfcd91aacf/JAH3-9-e014686-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/aa340d6e2493/JAH3-9-e014686-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/3257d413e444/JAH3-9-e014686-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/a4dfcd91aacf/JAH3-9-e014686-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/aa340d6e2493/JAH3-9-e014686-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/3257d413e444/JAH3-9-e014686-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d246/7033862/a4dfcd91aacf/JAH3-9-e014686-g003.jpg

相似文献

1
Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals.累积缺陷作为心血管发病率和死亡率的一个关键风险因素:154000 人的汇总分析。
J Am Heart Assoc. 2020 Feb 4;9(3):e014686. doi: 10.1161/JAHA.119.014686. Epub 2020 Jan 28.
2
Measuring Frailty Using Self-Report or Automated Tools to Identify Risk of Cardiovascular Events and Mortality: The Million Veteran Program.使用自我报告或自动化工具测量虚弱程度以识别心血管事件和死亡率风险:百万退伍军人计划。
J Am Heart Assoc. 2024 Aug 20;13(16):e033111. doi: 10.1161/JAHA.123.033111. Epub 2024 Aug 19.
3
Frailty as a Risk Factor for Cardiovascular Versus Noncardiovascular Mortality in Older Men: Results From the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study.衰弱作为老年男性心血管与非心血管死亡率的风险因素:来自 MrOS 睡眠研究(老年男性睡眠障碍结局研究)的结果。
J Am Heart Assoc. 2018 May 4;7(10):e008974. doi: 10.1161/JAHA.118.008974.
4
Physical Activity and Association Between Frailty and All-Cause and Cardiovascular Mortality in Older Adults: Population-Based Prospective Cohort Study.体力活动与老年人衰弱与全因及心血管死亡率的关系:基于人群的前瞻性队列研究。
J Am Geriatr Soc. 2018 Nov;66(11):2097-2103. doi: 10.1111/jgs.15542. Epub 2018 Oct 16.
5
The frailty index is a predictor of cause-specific mortality independent of familial effects from midlife onwards: a large cohort study.衰弱指数是从中年开始独立于家族影响预测特定原因死亡率的指标:一项大型队列研究。
BMC Med. 2019 May 15;17(1):94. doi: 10.1186/s12916-019-1331-8.
6
Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: An observational study.比较分析英格兰老年人群中 35 种衰弱评分与心血管事件、癌症和全因死亡率之间的关联:一项观察性研究。
PLoS Med. 2018 Mar 27;15(3):e1002543. doi: 10.1371/journal.pmed.1002543. eCollection 2018 Mar.
7
Frailty in relation to the risk of carotid atherosclerosis and cardiovascular events in Chinese community-dwelling older adults: A five-year prospective cohort study.中国社区居住的老年人群中,虚弱与颈动脉粥样硬化及心血管事件风险的关系:一项为期五年的前瞻性队列研究。
Exp Gerontol. 2023 Sep;180:112266. doi: 10.1016/j.exger.2023.112266. Epub 2023 Aug 2.
8
Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis.衰弱与糖尿病患者的死亡率、住院率和心血管疾病的关系:系统评价和荟萃分析。
Cardiovasc Diabetol. 2019 Jun 18;18(1):81. doi: 10.1186/s12933-019-0885-2.
9
Cardiovascular risk factors and frailty in a cross-sectional study of older people: implications for prevention.心血管危险因素与老年人横断面研究中的衰弱:对预防的启示。
Age Ageing. 2018 Sep 1;47(5):714-720. doi: 10.1093/ageing/afy080.
10
Frailty and Risk of Cardiovascular Diseases in Older Persons: The Age, Gene/Environment Susceptibility-Reykjavik Study.老年人的衰弱与心血管疾病风险:年龄、基因/环境易感性-雷克雅未克研究
Rejuvenation Res. 2017 Dec;20(6):517-524. doi: 10.1089/rej.2016.1905. Epub 2017 Aug 7.

引用本文的文献

1
Changes in Frailty and Cardiometabolic Disease: Evidence From a Longitudinal Cohort Study and Genetic Analysis.衰弱与心血管代谢疾病的变化:来自纵向队列研究和基因分析的证据
JACC Adv. 2025 Jun;4(6 Pt 2):101782. doi: 10.1016/j.jacadv.2025.101782.
2
Carotid Artery Stenting Intervention to Enhance Global Brain Blood Flow and Cognition in Carotid Artery Disease: Preliminary Findings from a Prospective Follow-Up MRI Study.颈动脉支架置入干预改善颈动脉疾病患者的全脑血流和认知功能:一项前瞻性随访MRI研究的初步结果
Medicina (Kaunas). 2025 May 5;61(5):848. doi: 10.3390/medicina61050848.
3
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.

本文引用的文献

1
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.在来自 21 个高收入、中等收入和低收入国家(PURE)的 155722 人中,可改变的风险因素、心血管疾病和死亡率:一项前瞻性队列研究。
Lancet. 2020 Mar 7;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2. Epub 2019 Sep 3.
2
Frailty and Multimorbidity: A Systematic Review and Meta-analysis.衰弱与多种共病:系统评价和荟萃分析。
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):659-666. doi: 10.1093/gerona/gly110.
3
Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: An observational study.
2型糖尿病降糖治疗随机对照试验中的衰弱:一项关于衰弱患病率、治疗效果及不良事件的个体参与者数据荟萃分析
PLoS Med. 2025 Apr 7;22(4):e1004553. doi: 10.1371/journal.pmed.1004553. eCollection 2025 Apr.
4
Predicting cardiovascular morbidity and mortality with SCORE2 (OP) and Framingham risk estimates in combination with indicators of biological ageing.结合生物学衰老指标,用SCORE2(OP)和弗雷明汉姆风险评估预测心血管疾病的发病率和死亡率。
Age Ageing. 2025 Mar 28;54(4). doi: 10.1093/ageing/afaf075.
5
Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy.既往虚弱对接受辅助治疗的乳腺癌患者心脏毒性的影响。
JACC CardioOncol. 2025 Feb;7(2):110-121. doi: 10.1016/j.jaccao.2024.10.012. Epub 2025 Jan 7.
6
Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction.心力衰竭中的衰弱决定因素:炎症标志物、认知障碍及社会心理相互作用
ESC Heart Fail. 2025 Jun;12(3):2010-2022. doi: 10.1002/ehf2.15208. Epub 2025 Jan 23.
7
Measuring Frailty Using Self-Report or Automated Tools to Identify Risk of Cardiovascular Events and Mortality: The Million Veteran Program.使用自我报告或自动化工具测量虚弱程度以识别心血管事件和死亡率风险:百万退伍军人计划。
J Am Heart Assoc. 2024 Aug 20;13(16):e033111. doi: 10.1161/JAHA.123.033111. Epub 2024 Aug 19.
8
Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data.评估衰弱老年人药物治疗的获益和危害:来自常规医疗保健数据的药物流行病学研究的启示。
Drugs Aging. 2024 Jul;41(7):583-600. doi: 10.1007/s40266-024-01121-0. Epub 2024 Jul 2.
9
Frailty and risk of systemic atherosclerosis: A bidirectional Mendelian randomization study.衰弱与系统性动脉粥样硬化风险:双向孟德尔随机化研究。
PLoS One. 2024 May 23;19(5):e0304300. doi: 10.1371/journal.pone.0304300. eCollection 2024.
10
Exploration of the causality of frailty index on psoriasis: A Mendelian randomization study.探讨脆弱指数与银屑病因果关系的孟德尔随机化研究。
Skin Res Technol. 2024 Mar;30(3):e13641. doi: 10.1111/srt.13641.
比较分析英格兰老年人群中 35 种衰弱评分与心血管事件、癌症和全因死亡率之间的关联:一项观察性研究。
PLoS Med. 2018 Mar 27;15(3):e1002543. doi: 10.1371/journal.pmed.1002543. eCollection 2018 Mar.
4
Multimorbidity and mortality in older adults: A systematic review and meta-analysis.老年人的多重疾病与死亡率:一项系统评价和荟萃分析。
Arch Gerontol Geriatr. 2016 Nov-Dec;67:130-8. doi: 10.1016/j.archger.2016.07.008. Epub 2016 Aug 2.
5
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.血压和胆固醇降低在无心血管疾病的人。
N Engl J Med. 2016 May 26;374(21):2032-43. doi: 10.1056/NEJMoa1600177. Epub 2016 Apr 2.
6
Accumulation of non-traditional risk factors for coronary heart disease is associated with incident coronary heart disease hospitalization and death.冠心病非传统风险因素的积累与冠心病住院和死亡事件相关。
PLoS One. 2014 Mar 13;9(3):e90475. doi: 10.1371/journal.pone.0090475. eCollection 2014.
7
Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.阿利吉仑单药治疗或与其他抗高血压药物联合用于临界高血压和1期高血压老年患者:APOLLO试验
Eur Heart J. 2014 Jul;35(26):1743-51. doi: 10.1093/eurheartj/ehu079. Epub 2014 Mar 9.
8
Validation of an index to estimate the prevalence of frailty among community-dwelling seniors.用于估计社区居住老年人衰弱患病率的指数验证
Health Rep. 2013 Sep;24(9):10-7.
9
Frailty consensus: a call to action.衰弱共识:行动呼吁。
J Am Med Dir Assoc. 2013 Jun;14(6):392-7. doi: 10.1016/j.jamda.2013.03.022.
10
Cardiovascular Disease Risk Assessment: Insights from Framingham.心血管疾病风险评估:来自弗雷明汉的见解。
Glob Heart. 2013 Mar;8(1):11-23. doi: 10.1016/j.gheart.2013.01.001.